1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Broadfin Capital, LLC Buys NanoString Technologies Inc, Xenon Pharmaceuticals Inc, La Jolla Pharmaceutical Co, Sells Mirati Therapeutics Inc, Endo International PLC, Exact Sciences Corp

New York, NY, based Investment company Broadfin Capital, LLC buys NanoString Technologies Inc, Xenon Pharmaceuticals Inc, La Jolla Pharmaceutical Co, Pacific Biosciences of California Inc, ADMA Biologics Inc, Intersect ENT Inc, AngioDynamics Inc, Idera Pharmaceuticals Inc, Alnylam Pharmaceuticals Inc, Tesaro Inc, sells Mirati Therapeutics Inc, Endo International PLC, Exact Sciences Corp, Horizon Pharma PLC, Dentsply Sirona Inc during the 3-months ended 2018-09-30, according to the most recent filings of the investment company, Broadfin Capital, LLC. As of 2018-09-30, Broadfin Capital, LLC owns 49 stocks with a total value of $676 million. These are the details of the buys and sells.

For the details of Broadfin Capital, LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Broadfin+Capital%2C+LLC

These are the top 5 holdings of Broadfin Capital, LLC
  1. iShares Russell 2000 (IWM) - 400,000 shares, 9.97% of the total portfolio.
  2. Iovance Biotherapeutics Inc (IOVA) - 4,894,361 shares, 8.14% of the total portfolio. Shares added by 18.03%
  3. La Jolla Pharmaceutical Co (LJPC) - 2,053,991 shares, 6.12% of the total portfolio. Shares added by 37.43%
  4. Zogenix Inc (ZGNX) - 657,898 shares, 4.83% of the total portfolio. Shares added by 5.71%
  5. ADMA Biologics Inc (ADMA) - 4,463,829 shares, 4.1% of the total portfolio. Shares added by 37.36%
New Purchase: NanoString Technologies Inc (NSTG)

Broadfin Capital, LLC initiated holding in NanoString Technologies Inc. The purchase prices were between $11.36 and $18.21, with an estimated average price of $14.61. The stock is now traded at around $15.66. The impact to a portfolio due to this purchase was 2.24%. The holding were 850,000 shares as of 2018-09-30.

New Purchase: Xenon Pharmaceuticals Inc (XENE)

Broadfin Capital, LLC initiated holding in Xenon Pharmaceuticals Inc. The purchase prices were between $9 and $14.9, with an estimated average price of $11.58. The stock is now traded at around $8.49. The impact to a portfolio due to this purchase was 1.75%. The holding were 895,553 shares as of 2018-09-30.

New Purchase: Intersect ENT Inc (XENT)

Broadfin Capital, LLC initiated holding in Intersect ENT Inc. The purchase prices were between $26.05 and $36.6, with an estimated average price of $30.11. The stock is now traded at around $30.50. The impact to a portfolio due to this purchase was 1%. The holding were 234,200 shares as of 2018-09-30.

New Purchase: AngioDynamics Inc (ANGO)

Broadfin Capital, LLC initiated holding in AngioDynamics Inc. The purchase prices were between $18.95 and $24.23, with an estimated average price of $22.22. The stock is now traded at around $19.50. The impact to a portfolio due to this purchase was 0.93%. The holding were 289,035 shares as of 2018-09-30.

New Purchase: Idera Pharmaceuticals Inc (IDRA)

Broadfin Capital, LLC initiated holding in Idera Pharmaceuticals Inc. The purchase prices were between $5.53 and $11.36, with an estimated average price of $8.47. The stock is now traded at around $7.75. The impact to a portfolio due to this purchase was 0.83%. The holding were 629,340 shares as of 2018-09-30.

New Purchase: Alnylam Pharmaceuticals Inc (ALNY)

Broadfin Capital, LLC initiated holding in Alnylam Pharmaceuticals Inc. The purchase prices were between $87.52 and $122.67, with an estimated average price of $100.59. The stock is now traded at around $68.32. The impact to a portfolio due to this purchase was 0.81%. The holding were 62,200 shares as of 2018-09-30.

Added: La Jolla Pharmaceutical Co (LJPC)

Broadfin Capital, LLC added to a holding in La Jolla Pharmaceutical Co by 37.43%. The purchase prices were between $20.13 and $34.02, with an estimated average price of $26.12. The stock is now traded at around $15.19. The impact to a portfolio due to this purchase was 1.67%. The holding were 2,053,991 shares as of 2018-09-30.

Added: Pacific Biosciences of California Inc (PACB)

Broadfin Capital, LLC added to a holding in Pacific Biosciences of California Inc by 136.51%. The purchase prices were between $3.52 and $5.55, with an estimated average price of $4.29. The stock is now traded at around $7.69. The impact to a portfolio due to this purchase was 1.15%. The holding were 2,493,021 shares as of 2018-09-30.

Added: ADMA Biologics Inc (ADMA)

Broadfin Capital, LLC added to a holding in ADMA Biologics Inc by 37.36%. The purchase prices were between $4.39 and $6.85, with an estimated average price of $5.75. The stock is now traded at around $5.11. The impact to a portfolio due to this purchase was 1.12%. The holding were 4,463,829 shares as of 2018-09-30.

Added: Sierra Oncology Inc (SRRA)

Broadfin Capital, LLC added to a holding in Sierra Oncology Inc by 94.17%. The purchase prices were between $1.7 and $3.08, with an estimated average price of $2.27. The stock is now traded at around $1.66. The impact to a portfolio due to this purchase was 0.5%. The holding were 4,090,344 shares as of 2018-09-30.

Added: Quotient Ltd (QTNT)

Broadfin Capital, LLC added to a holding in Quotient Ltd by 83.01%. The purchase prices were between $6.57 and $8.31, with an estimated average price of $7.51. The stock is now traded at around $6.24. The impact to a portfolio due to this purchase was 0.41%. The holding were 804,700 shares as of 2018-09-30.

Added: Integra Lifesciences Holdings Corp (IART)

Broadfin Capital, LLC added to a holding in Integra Lifesciences Holdings Corp by 20.28%. The purchase prices were between $57.63 and $65.87, with an estimated average price of $62.11. The stock is now traded at around $52.78. The impact to a portfolio due to this purchase was 0.32%. The holding were 196,572 shares as of 2018-09-30.

Sold Out: Endo International PLC (ENDP)

Broadfin Capital, LLC sold out a holding in Endo International PLC. The sale prices were between $9.77 and $17.15, with an estimated average price of $14.18.

Sold Out: Exact Sciences Corp (EXAS)

Broadfin Capital, LLC sold out a holding in Exact Sciences Corp. The sale prices were between $48.29 and $80.6, with an estimated average price of $65.21.

Sold Out: Dentsply Sirona Inc (XRAY)

Broadfin Capital, LLC sold out a holding in Dentsply Sirona Inc. The sale prices were between $37.45 and $48.44, with an estimated average price of $41.66.

Sold Out: Mettler-Toledo International Inc (MTD)

Broadfin Capital, LLC sold out a holding in Mettler-Toledo International Inc. The sale prices were between $559.44 and $617.94, with an estimated average price of $588.21.

Sold Out: Xeris Pharmaceuticals Inc (XERS)

Broadfin Capital, LLC sold out a holding in Xeris Pharmaceuticals Inc. The sale prices were between $17.58 and $27.23, with an estimated average price of $21.71.

Sold Out: Global Blood Therapeutics Inc (GBT)

Broadfin Capital, LLC sold out a holding in Global Blood Therapeutics Inc. The sale prices were between $38 and $51.1, with an estimated average price of $44.38.



Here is the complete portfolio of Broadfin Capital, LLC. Also check out:

1. Broadfin Capital, LLC's Undervalued Stocks
2. Broadfin Capital, LLC's Top Growth Companies, and
3. Broadfin Capital, LLC's High Yield stocks
4. Stocks that Broadfin Capital, LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


jbostwickosv growth small sort by marke
TarunEarngs gth, buybacks 0
TarunEarngs gth, buybacks
TarunP/S, buybacks
TarunP/E, buybacks
scott.hollenbergScreen 1
DANGORDONROC ROE 1YR RETURN
pbarker46Buying & selling guidlines
alexjestestje1
alexjestestje
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK